Answers are grounded in this paper and cite their sources.
This Viewpoint examines the approval of the first quality metric for head and neck oncology and potential outcomes for improving quality of care for patients with head and neck squamous cell carcinoma.
No takes yet. Share an insight, caveat, or question.
Graboyes et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: